Document:

Form of Incentive/Nonqualified Stock Option Agreement

 Exhibit 10.80 
  
 CORTEX PHARMACEUTICALS, INC. 
  

(Incentive or Non-qualified) Stock Option Agreement 
  
 Agreement No.               
  
 This Stock Option Agreement (“Agreement”) is entered into as of
                     by and between Cortex Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and
                     (the “Optionee”) pursuant to the Company’s 1996 Stock Incentive Plan (the “Plan”). 

 
 1. Grant of
Option. The Company hereby grants to Optionee an option (the “Option”) to purchase all or any portion of a total of              shares (the
“Shares”) of the Common Stock of the Company at a purchase price of $             per share (the “Exercise Price”), subject to the terms and conditions set forth
herein and the provisions of the Plan. 
  
 If the Notice of Grant of Stock Options
(the “Notice of Grant”) dated                      and accompanying this Agreement indicates that this is an “Incentive”
option, then this Option is intended to qualify as an “incentive stock option” as defined in Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”). If this Option fails in whole or in part to qualify as an
incentive stock option, or if the Notice of Grant indicates the Option is a “Nonqualified” option, then this Option shall to that extent be a nonqualified stock option. 
  
 2. Vesting of Option. The right to exercise this Option shall vest in installments, and this Option
shall be exercisable from time to time in whole or in part as to any vested installment, in accordance with the vesting schedule as provided in the Notice of Grant. 
  
 No additional shares shall vest after, and the portion of the Option related to such additional shares shall terminate upon the date of,
termination of Optionee’s “Continuous Service” (as defined in Section 3 below), but this Option shall continue to be exercisable in accordance with Section 3 hereof with respect to that number of shares that have vested as of the date
of termination of Optionee’s Continuous Service. 
  
 3. Term of Option. Optionee’s right to exercise this Option shall terminate upon the first to occur of the following: 
  
 (a) the expiration of              years from the date of this Agreement; 

 
 (b) the expiration of three months from the date of termination of
Optionee’s Continuous Service if such termination occurs for any reason other than permanent disability or death; provided, however, that if Optionee dies during such three-month period the provisions of Section 3(d) below shall apply;

 (c) the expiration of one year from the date of termination of Optionee’s Continuous Service if such
termination is due to permanent disability of the Optionee (as defined in Section 22(e)(3) of the Code); or 
  
 (d) the expiration of one year from the date of termination of Optionee’s Continuous Service if such termination is due to Optionee’s death or
if death occurs during the period following termination of Optionee’s Continuous Service pursuant to Section 3(b) above; 
  
 (e) the consummation of a Change in Control unless otherwise provided pursuant to Section 8 hereof. 
  
 As used herein, the term “Continuous Service” means (i) employment
by either the Company or any parent or subsidiary corporation of the Company, or by a corporation or a parent or subsidiary of a corporation issuing or assuming a stock option in a transaction to which Section 424(a) of the Code applies, which is
uninterrupted except for vacations, illness (except for permanent disability, as defined in Section 22(e)(3) of the Code), or leaves of absence which are approved in writing by the Company or any of such other employer corporations, if applicable,
(ii) service as a member of the Board of Directors of the Company until Optionee resigns, is removed from office, or Optionee’s term of office expires and he or she is not reelected, or (iii) so long as Optionee is engaged as a consultant or
service provider to the Company or other corporation referred to in clause (i) above. 
  
 4. Exercise of Option. Prior to termination of this Option in accordance with Section 3 above, this Option may be exercised in whole or in part by the Optionee (or, after his or her death, by the
person designated in Section 5 below) upon delivery of the following to the Company at its principal executive offices: 
  
 (a) a written notice of exercise that identifies this Agreement and states the number of Shares then being purchased (but no fractional Shares may be
purchased); 
  
 (b) a check or cash in the amount of the Exercise
Price (or payment of the Exercise Price in such other form of lawful consideration as the Administrator may approve from time to time under the provisions of Section 5.3 of the Plan); and 
  
 (c) a check or cash in the amount reasonably requested by the Company to satisfy the Company’s withholding obligations
under federal, state or other applicable tax laws with respect to the taxable income, if any, recognized by the Optionee in connection with the exercise of this Option (unless the Company and Optionee shall have made other arrangements for
deductions or withholding from Optionee’s wages, bonus or other compensation payable to Optionee, provided such arrangements satisfy the requirements of applicable tax laws in the opinion of the Company’s tax advisors). 
  

 2 

 5. Death of Optionee; No Assignment. The rights of the Optionee under this Agreement
may not be assigned or transferred except by will or by the laws of descent and distribution, and may be exercised during the lifetime of the Optionee only by such Optionee. Any attempt to sell, pledge, assign, hypothecate, transfer or dispose of
this Option in contravention of this Agreement or the Plan shall be void and shall have no effect. If the Optionee’s Continuous Service terminates as a result of his or her death, and provided Optionee’s rights hereunder shall have vested
pursuant to Section 2 hereof, Optionee’s legal representative, his or her legatee, or the person who acquired the right to exercise this Option by reason of the death of the Optionee (individually, a “Successor”) shall succeed to the
Optionee’s rights and obligations under this Agreement. After the death of the Optionee, only a Successor may exercise this Option. 
  
 6. Limitation of Company’s Liability for Nonissuance. The Company agrees to use its reasonable best efforts to obtain from any
applicable regulatory agency such authority or approval as may be required in order to issue and sell the Shares to the Optionee pursuant to this Option. Inability of the Company to obtain, from any such regulatory agency, authority or approval
deemed by the Company’s counsel to be necessary for the lawful issuance and sale of the Shares hereunder and under the Plan shall relieve the Company of any liability in respect of the nonissuance or sale of such shares as to which such
requisite authority or approval shall not have been obtained. 
  
 7. Adjustments Upon Changes in Capital Structure. In the event that the outstanding shares of Common Stock of the Company are hereafter increased or decreased or changed into or exchanged for a different number or kind
of shares or other securities of the Company by reason of a recapitalization, stock split, combination of shares, reclassification, stock dividend or other change in the capital structure of the Company, then appropriate adjustments shall be made by
the Administrator to the number of Shares subject to the unexercised portion of this Option and to the Exercise Price per share, in order to preserve, as nearly as practical, but not to increase, the benefits of the Optionee under this Option, in
accordance with the provisions of Section 4.2 of the Plan. 
  
 8. Change in Control. In the event of a Change in Control (as defined below) of the Company, the Administrator in its discretion may take one or more of the following actions: (a) provide for the purchase of this Option
for an amount of cash or other property that could have been received upon the exercise of this Option had this Option been currently exercisable, (b) adjust the terms of this Option in a manner determined by the Administrator to reflect the Change
in Control, (c) cause the Option to be continued or assumed, or new rights substituted therefor, by the surviving or another entity, through the continuance of the Plan and the continuation or assumption of this Option, or the substitution for this
Option of a new option of comparable value covering shares of a successor corporation, with appropriate adjustments as to the number and kind of shares and Exercise Price, in which event the Plan and this Option, or the new option 
  

 3 

 shall continue in the manner and under terms so provided or (d) make such other provision as the Administrator may
consider equitable. If the Administrator does not take any of the forgoing actions, this Option shall terminate upon the consummation of the Change in Control and the Administrator shall cause written notice of the proposed transaction to be given
to the Optionee not less than fifteen (15) days prior to the anticipated effective date of the proposed transaction, provided however that whether or not provision is made for continuance of the Plan and the continuance, assumption or substitution
of outstanding Options, then concurrent with the effective date of the Change of Control, all Options not previously terminated shall be accelerated and concurrent with such date, the holders of such Options shall have the right to exercise such
Options in respect to any or all shares subject thereto. 
  
 For
purposes of this Agreement, the term “Change in Control” shall mean (i) the acquisition, directly or indirectly, by any person or group (within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended) of the
beneficial ownership of more than fifty percent (50%) of the outstanding securities of the Company; (ii) a merger or consolidation in which the Company is not the surviving entity, except for a transaction the principal purpose of which is to change
the state in which the Company is incorporated; (iii) the sale, transfer or other disposition of all or substantially all of the assets of the Company; (iv) a complete liquidation or dissolution of the Company; or (v) any reverse merger in which the
Company is the surviving entity but in which securities possessing more than fifty percent (50%) of the total combined voting power of the Company’s outstanding securities are transferred to a person or persons different from the persons
holding those securities immediately prior to such merger. 
  
 9. No Employment Contract Created. Neither the granting of this Option nor the exercise hereof shall be construed as granting to the Optionee any right with respect to continuance of employment by the Company or any of
its subsidiaries. The right of the Company or any of its subsidiaries to terminate at will the Optionee’s employment at any time (whether by dismissal, discharge or otherwise), with or without cause, is specifically reserved. 
  
 10. Rights as Shareholder. The Optionee (or transferee
of this option by will or by the laws of descent and distribution) shall have no rights as a shareholder with respect to any Shares covered by this Option until such Option has been duly exercised and certificates representing shares purchased upon
such exercise have been issued to such person. 
  
 11.
“Market Stand-Off” Agreement. Optionee agrees that, if requested by the Company or the managing underwriter of any proposed public offering of the Company’s securities, Optionee will not sell or otherwise transfer or
dispose of any Shares held by Optionee without the prior written consent of the Company or such underwriter, as the case may be, during such period of time, not to exceed 180 days following the effective date of the registration statement filed by
the Company with respect to such offering, as the Company or the underwriter may specify. 
  

 4 

 12. Interpretation. This Option is granted pursuant to the terms of the Plan, and
shall in all respects be interpreted in accordance therewith. The Administrator shall interpret and construe this Option and the Plan, and any action, decision, interpretation or determination made in good faith by the Administrator shall be final
and binding on the Company and the Optionee. As used in this Agreement, the term “Administrator” shall refer to the committee of the Board of Directors of the Company appointed to administer the Plan, and if no such committee has been
appointed, the term Administrator shall mean the Board of Directors. 
  
 13. Notices. Any notice, demand or request required or permitted to be given under this Agreement shall be in writing and shall be deemed given when delivered personally or three days after being deposited in the United
States mail, as certified or registered mail, with postage prepaid and addressed, if to the Company, at its principal place of business, Attention: Chief Financial Officer, and if to the Optionee, at his or her most recent address as shown in the
employment or stock records of the Company. 
  
 14.
Annual and Other Periodic Reports. During the term of this Agreement, the Company will furnish to the Optionee copies of all annual and other periodic financial and informational reports that the Company distributes generally to its
shareholders. 
  
 15. Governing Law. The
validity, construction, interpretation and effect of this Option shall be governed by and determined in accordance with the laws of the State of Delaware. 
  
 16. Severability. Should any provision or portion of this Agreement be held to be unenforceable or invalid for any reason, the
remaining provisions and portions of this Agreement shall be unaffected by such holding. 
  
 17. Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original and all of which together shall be deemed one instrument. 
  

 5 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written.

  

					
	CORTEX PHARMACEUTICALS, INC.,	 	“OPTIONEE”
	a Delaware corporation	 	 
			
	By:	 	  

	 	  

	 	 	 	 	Signature
			
	Its:	 	  

	 	 

  

 6Form of Restricted Stock Award

 Exhibit 10.81 
  
 CORTEX PHARMACEUTICALS, INC. 
 RESTRICTED STOCK AWARD AGREEMENT 
 UNDER 
 1996 STOCK INCENTIVE PLAN 
  
 THIS RESTRICTED STOCK AWARD AGREEMENT (the “Agreement”) is entered into as of
                             by and between
                             (hereinafter referred to as “Grantee”), and Cortex
Pharmaceuticals, Inc., a Delaware corporation (hereinafter referred to as the “Company”), pursuant to the Company’s 1996 Stock Incentive Plan (the “Plan”). Any capitalized term not defined herein shall have the same meaning
ascribed to it in the Plan. 
  
 R E C I T A L S: 

 
 A. Grantee is an employee, director, consultant or other Service
Provider, and in connection therewith has rendered services for and on behalf of the Company. 
  
 B. The Company desires to issue shares of common stock to Grantee to encourage the continued service of Grantee as an employee of the Company and to exert added effort towards its growth and success, which
service is of benefit to the Company. 
  
 C. The Company
desires to impose certain restrictions on the shares of Common Stock granted hereunder for the benefit of the Company. 
  
 D. Such grant is being made to Grantee in addition to, and not in lieu of, any other form of compensation otherwise payable or to be paid to
Grantee. 
  
 NOW, THEREFORE, in consideration of the mutual
covenants hereinafter set forth, and for other good and valuable consideration, the parties agree as follows: 
  
 1. Issuance of Shares. The Company hereby offers to issue to Grantee an aggregate of
                             shares of Common Stock of the Company (the “Shares”) on the
terms and conditions herein set forth. Unless this offer is earlier revoked in writing by the Company, Grantee shall have ten (10) days from the date of the delivery of this Agreement to Grantee to accept the offer of the Company by executing and
delivering to the Company two copies of this Agreement, without condition or reservation of any kind whatsoever. 
  
 2. Vesting of Shares. 
  
 (a) Subject to Sections 2(b)-(c) below, the Shares acquired hereunder shall vest and become “Vested Shares” as to
                         Percent (    %) of the Shares on the first anniversary of the
effective date of this Agreement, and thereafter, the balance of the Shares shall become Vested Shares in a series of
                             (    ) successive equal annual installments
for each year of Continuous Service provided by the Grantee, such that 100% of the Shares shall be Vested Shares on the
                             anniversary of this Agreement. Shares which have not yet become vested
are herein called “Unvested Shares.” No additional shares shall vest after the date of termination of Grantee’s Continuous Service. 
  
 As used herein, the term “Continuous Service” means (i) employment by either the Company or any parent or subsidiary corporation of the Company,
or by any successor entity 

 following a Change in Control, which is uninterrupted except for vacations, illness (except for permanent disability, as
defined in Section 22(e)(3) of the Code), or leaves of absence which are approved in writing by the Company or any of such other employer corporations, if applicable, (ii) service as a member of the Board of Directors of the Company until Grantee
resigns, is removed from office, or Grantee’s term of office expires and he or she is not reelected, or (iii) so long as Grantee is engaged as a consultant or Service Provider to the Company or other corporation referred to in clause (i) above.

  
 (b) Notwithstanding Section 2(a), if Grantee holds
Shares at the time a Change in Control occurs, all Forefeiture Rights shall automatically terminate immediately prior to the consummation of such Change in Control, and the Shares subject to those terminated Forefeiture Rights shall immediately vest
in full, except to the extent that this Agreement is continued, assumed, or substituted for by the acquiring or successor entity (or parent thereof) in connection with such Change in Control. If the Forefeiture Rights automatically terminate
in accordance with the provisions of this subsection (b), then the Administrator shall cause written notice of the Change in Control transaction to be given to Grantee not less than fifteen (15) days prior to the anticipated effective date of the
proposed transaction. 
  
 (c) However, if in the event of a
Change in Control the acquiring or successor entity (or parent thereof) provides for the continuance or assumption of this Agreement or the substitution for this Agreement of a new agreement of comparable value covering shares of a successor
corporation (with appropriate adjustments as to the number and kind of shares and the purchase price), then the Forefeiture Rights shall not terminate, and vesting of the Shares shall continue in accordance with Section 2(a) above. 
  
 (d) IF, WITH RESPECT TO ANY UNVESTED SHARES, THE GRANTEE WISHES TO
MAKE THE ELECTION SET FORTH IN SECTION 83(B) OF THE CODE, HE OR SHE MUST DELIVER TO THE COMPANY A COPY OF THE SIGNED AND COMPLETED NOTICE OF ELECTION THAT GRANTEE FILED WITH THE INTERNAL REVENUE SERVICE WITHIN THIRTY (30) DAYS OF THE DATE SPECIFIED
IN THE FIRST PARAGRAPH OF THIS AGREEMENT. A FORM OF ELECTION IS ATTACHED HERETO AND LABELED EXHIBIT A. 
  
 3. Forfeiture Rights Upon Termination of Service. 
  

(a) Deposit of Unvested Shares. Grantee shall deposit with the Company certificates representing the Unvested Shares, together with a duly
executed stock assignment separate from certificate in blank (a form of which is attached hereto as Exhibit B), which shall be held by the Secretary of the Company. Grantee shall be entitled to vote and to receive dividends and distributions
on all such deposited Unvested Shares. 
  
 (b) Forfeiture and
Cancellation of Unvested Shares upon Termination. In the event that the Grantee’s Continuous Service terminates for any reason, all Unvested Shares as of the Termination Date shall be immediately forfeited, cancelled and shall become null
and void (the “Forfeiture Rights”). The Company shall cancel the certificates then deposited with the Company evidencing the Unvested Shares and reissue a new certificate to Grantee evidencing only the Vested Shares, if any, as of the
Termination Date. 
  

 2 

 (c) Termination. The provisions of this Section 3 shall automatically terminate in accordance with
Section 2(b) above. 
  
 (d) Assignment. The Company may
assign its right under this Section 3 without the consent of the Grantee. 
  
 4. Restrictions on Unvested Shares. Unvested Shares may not be sold, transferred, pledged, or otherwise disposed of, except that such Unvested Shares may be transferred to a trust established for the
sole benefit of the Grantee and/or his or her spouse, children or grandchildren. Any Unvested Shares that are transferred as provided herein remain subject to the terms and conditions of this Agreement. 
  
 5. Adjustments Upon Changes in Capital Structure. In the event
that the outstanding Shares of Common Stock of the Company are hereafter increased or decreased or changed into or exchanged for a different number or kind of shares or other securities of the Company by reason of a recapitalization, stock split,
combination of shares, reclassification, stock dividend, or other change in the capital structure of the Company, then Grantee shall be entitled to new or additional or different shares of stock or securities, in order to preserve, as nearly as
practical, but not to increase, the benefits of Grantee under this Agreement, in accordance with the provisions of Section 4.2 of the Plan. Such new, additional or different shares shall be deemed “Shares” for purposes of this Agreement
and subject to all of the terms and conditions hereof. 
  
 6.
Shares Free and Clear. All Shares returned to the Company pursuant to this Agreement shall be delivered by Grantee free and clear of all claims, liens and encumbrances of every nature (except the provisions of this Agreement and any
conditions concerning the Shares relating to compliance with applicable federal or state securities laws), and the Company shall acquire full and complete title and right to all of such Shares, free and clear of any claims, liens and encumbrances of
every nature (again, except for the provisions of this Agreement and such securities laws). 
  
 7. Limitation of Company’s Liability for Nonissuance; Unpermitted Transfers. 
  
 (a) The Company agrees to use its reasonable best efforts to obtain from any applicable regulatory agency such authority or approval as may be
required in order to issue and sell the Shares to Grantee pursuant to this Agreement. The inability of the Company to obtain, from any such regulatory agency, authority or approval deemed by the Company’s counsel to be necessary for the lawful
issuance and sale of the Shares hereunder and under the Plan shall relieve the Company of any liability in respect of the nonissuance or sale of such Shares as to which such requisite authority or approval shall not have been obtained. 

 
 (b) The Company shall not be required to: (i) transfer on its books
any Shares of the Company which shall have been sold or transferred in violation of any of the provisions set forth in this Agreement, or (ii) treat as owner of such shares or to accord the right to vote as such owner or to pay dividends to any
transferee to whom such shares shall have been so transferred. 
  
 8. Notices. Any notice, demand or request required or permitted to be given under this Agreement shall be in writing and shall be deemed given when delivered personally or three (3) days after being deposited in the United
States mail, as certified or registered mail, with postage prepaid, (or by such other method as the Administrator may from time to time deem appropriate), and 
  

 3 

 addressed, if to the Company, at its principal place of business, Attention: Chief Financial Officer, and if to the
Grantee, at his or her most recent address as shown in the employment or stock records of the Company. 
  
 9. Binding Obligations. All covenants and agreements herein contained by or on behalf of any of the parties hereto shall bind and inure to
the benefit of the parties hereto and their permitted successors and assigns. 
  
 10. Captions and Section Headings. Captions and section headings used herein are for convenience only, and are not part of this Agreement and shall not be used in construing it. 
  
 11. Amendment. This Agreement may not be amended, waived,
discharged, or terminated other than by written agreement of the parties. 
  
 12. Entire Agreement. This Agreement and the Plan constitute the entire agreement between the parties with respect to the subject matter hereof and supersede all prior or contemporaneous written or oral
agreements and understandings of the parties, either express or implied. 
  
 13. Assignment. Grantee shall have no right, without the prior written consent of the Company, to (i) sell, assign, mortgage, pledge or otherwise transfer any interest or right created hereby, or (ii)
delegate his or her duties or obligations under this Agreement. This Agreement is made solely for the benefit of the parties hereto, and no other person, partnership, association or corporation shall acquire or have any right under or by virtue of
this Agreement. 
  
 14. Severability. Should any
provision or portion of this Agreement be held to be unenforceable or invalid for any reason, the remaining provisions and portions of this Agreement shall be unaffected by such holding. 
  
 15. Counterparts. This Agreement may be executed in one or more counterparts, all of which taken together
shall constitute one agreement and any party hereto may execute this Agreement by signing any such counterpart. This Agreement shall be binding upon Grantee and the Company at such time as the Agreement, in counterpart or otherwise, is executed by
Grantee and the Company. 
  
 16. Governing Law. This
Agreement shall be construed in accordance with the laws of the State of Delaware without reference to choice of law principles, as to all matters, including, but not limited to, matters of validity, construction, effect or performance. 

 
 17. No Agreement to Employ. Nothing in this Agreement shall
affect any right with respect to continuance of employment by the Company or any of its subsidiaries. The right of the Company or any of its subsidiaries to terminate at will the Grantee’s employment at any time (whether by dismissal, discharge
or otherwise), with or without cause, is specifically reserved, subject to any other written employment agreement to which the Company and Grantee may be a party. 
  
 18. “Market Stand-Off” Agreement. Grantee agrees that, if requested by the Company or the managing
underwriter of any proposed public offering of the Company’s securities, Grantee will not sell or otherwise transfer or dispose of any Shares held by Grantee without the prior written 
  

 4 

 consent of the Company or such underwriter, as the case may be, during such period of time, not to exceed 180 days
following the effective date of the registration statement filed by the Company with respect to such offering, as the Company or the underwriter may specify. 
  
 19. Withholding. Grantee agrees to promptly pay the Company an aggregate amount sufficient to satisfy all Federal, state, local and foreign
income and employment withholding tax requirements applicable to the issuance and vesting of the Shares as contemplated by this Agreement. In particular, and without limitation, in the event that Grantee declines to make an election under Section
83(b) of the Code, Grantee agrees to promptly pay the Company an amount sufficient to satisfy the aforementioned tax requirements on each date during the term of the Agreement when a portion of the Shares acquired hereunder become Vested Shares.

  
 20. Tax Elections. GRANTEE UNDERSTANDS THAT
GRANTEE (AND NOT THE COMPANY) SHALL BE RESPONSIBLE FOR THE GRANTEE’S OWN TAX LIABILITY THAT MAY ARISE AS A RESULT OF THE ACQUISITION OF THE SHARES. GRANTEE ACKNOWLEDGES THAT GRANTEE HAS CONSIDERED THE ADVISABILITY OF ALL TAX ELECTIONS IN
CONNECTION WITH THE ISSUANCE OF THE SHARES, INCLUDING THE MAKING OF AN ELECTION UNDER SECTION 83(b) UNDER THE CODE; GRANTEE FURTHER ACKNOWLEDGES THAT THE COMPANY HAS NO RESPONSIBILITY FOR THE MAKING OF SUCH SECTION 83(b) ELECTION. IN THE EVENT
GRANTEE DETERMINES TO MAKE A SECTION 83(b) ELECTION, GRANTEE AGREES TO TIMELY PROVIDE A COPY OF THE ELECTION TO THE COMPANY AS REQUIRED UNDER THE CODE. 
  
 21. Attorneys’ Fees. If any party shall bring an action in law or equity against another to enforce or interpret any of the terms,
covenants and provisions of this Agreement, the prevailing party in such action shall be entitled to recover from the other party reasonable attorneys’ fees and costs. 
  
 [Signature Page Follows] 
  

 5 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.

  

							
	 THE COMPANY:
	 	 GRANTEE:

			
	 CORTEX PHARMACEUTICALS, INC.
	 	 	 	 
			
	 By:
	 	  

	 	

	 Name:
	 	  

	 	 	 	 
	 Title:
	 	  

	 	 	 	 
	 	 	 	 	 Address:
	 	 
	 	 	 	 	  

	 	 	 	 	  

  

 6 

 CONSENT AND RATIFICATION OF SPOUSE 
  
 The undersigned, the spouse of
                            , a party to the attached Restricted Stock Award Agreement (the
“Agreement”), dated as of                             , hereby consents to the execution of
said Agreement by such party; and ratifies, approves, confirms and adopts said Agreement, and agrees to be bound by each and every term and condition thereof as if the undersigned had been a signatory to said Agreement, with respect to the Shares
(as defined in the Agreement) made the subject of said Agreement in which the undersigned has an interest, including any community property interest therein. 
  
 I also acknowledge that I have been advised to obtain independent counsel to represent my interests with respect to this Agreement but that I have
declined to do so and I hereby expressly waive my right to such independent counsel. 
  

					
	 Date:
	 	  

	 	  

	 	 	 	 	(Signature)
	 	 	 	 	  

	 	 	 	 	(Print Name)

  

 EXHIBIT A 
  

ELECTION TO INCLUDE IN GROSS INCOME IN YEAR OF GRANT OF RESTRICTED SHARES 
 PURSUANT TO SECTION 83(b) OF THE INTERNAL REVENUE CODE OF 1986 (AS AMENDED) 
  
 The undersigned hereby elects pursuant to Section 83(b) of the Internal Revenue Code of 1986 (as amended) with respect to the property described below and
supplies the following information in accordance with the regulations promulgated thereunder: 
  

	1.	The Name, Address and Taxpayer Identification Number of the person making this election and such person’s spouse, if any: 

  

			
	 Name :
	 	  

		
	 Address:
	 	  

	 	 	  

	 Taxpayer Identification Number:
	 	  

  

	2.	Description of the property with respect to which the election is being made: 

  
              (number of shares) of Common Stock, par
value $             per share, of Cortex Pharmaceuticals, Inc. 
  

	3.	The date on which property was transferred is
                             (date specified in first paragraph of the Agreement).

  

	4.	The taxable year to which this election relates is calendar year             .

  

	5.	The Fair Market Value. 

  
 The fair market value on the date specified in Item 3 above (determined without regard to any restrictions other than restrictions which by their terms
never lapse) of the property with respect to which this election is being made is $             per share. 
  

	6.	Amount paid for the property transferred. 

  
 The amount paid by the taxpayer for the property specified in Item 2 above is
$             per share. 
  

	7.	Furnishing statement to the Company. 

  
 A copy of this statement has been furnished to Cortex Pharmaceuticals, Inc. 
  

					
	 Dated:
	 	  

	  	  

	 	 	 	  	(name of taxpayer)

  

 A-1 

 EXHIBIT B 
  

STOCK ASSIGNMENT SEPARATE FROM CERTIFICATE 
  
 FOR VALUE RECEIVED, the undersigned,
                            , hereby assigns and transfers unto Cortex Pharmaceuticals, Inc., a
Delaware corporation (“Cortex”), a total of              shares of the Common Stock of Cortex, standing in its name on the books of said Corporation represented by
Certificate No.             , and does hereby irrevocably constitute and appoint
                             as its attorney, to transfer said shares on the share register of the
within named Corporation, with full power of substitution. 
  

					
	 Dated:             , 200  
	 	By:	 	  

	 	 	 	 	 [Name Printed]

  

 B-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00072-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00072-of-00352.parquet"}]]